Skip to main content
SpringerLink
Log in

Adjuvant Agents in Chronic Pain Therapy

  • Chapter
  • First Online:
Controlled Substance Management in Chronic Pain

Abstract

Adjuvant agents play a crucial role in the care of chronic pain patients but there is little in the literature to inform prescribing choices for this particular population. The most commonly prescribed adjuvant agents for chronic pain include antidepressants, anticonvulsants, and muscle relaxants.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rasu RS, Vouthy K, Crowl AN, Stegeman AE, Fikru B, Bawa WA, et al. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States. J Managed Care Pharm JMCP. 2014;20(9):921–8 Epub 2014/08/29.

    Article  Google Scholar 

  2. Lussier D, Portenoy R. Adjuvant analgesics in pain management. In: Doyle D, Hanks G, Christakis N, editors. Oxford textbook of palliative medicine. 3rd ed. Oxford, England: Oxford University Press; 2003. pp. 349–77.

    Google Scholar 

  3. Khan MI, Walsh D, Brito-Dellan N. Opioid and adjuvant analgesics: compared and contrasted. Am J Hospice Palliat Care. 2011;28(5):378–83 Epub 2011/05/31.

    Article  Google Scholar 

  4. Gilron I, Max M. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother. 2005;5(6):823–30.

    Article  CAS  PubMed  Google Scholar 

  5. Pergolizzi JV, Gharibo C, Ho KY. Treatment considerations for cancer pain: a global perspective. Pain Pract Official J World Inst Pain. 2014 Epub 2014/12/04.

    Google Scholar 

  6. Muller-Schwefe G, Ahlbeck K, Aldington D, Alon E, Coaccioli S, Coluzzi F, et al. Pain in the cancer patient: different pain characteristics CHANGE pharmacological treatment requirements. Curr Med Res Opin. 2014;30(9):1895–908 Epub 2014/05/21.

    Article  PubMed  CAS  Google Scholar 

  7. Smith H. A comprehensive review of rapid-onset opioids for breakthrough pain. CNS Drugs. 2012;26(6):509–35 Epub 2012/06/07.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Coluzzi F, Mattia C. Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants. Curr Pharm Des. 2005;11(23):2945–60 Epub 2005/09/24.

    Article  CAS  PubMed  Google Scholar 

  9. Sawynok J. Antidepressants as analgesics: an introduction. J Psychiatry Neurosci JPN. 2001;26(1):20 Epub 2001/02/24.

    Google Scholar 

  10. Robinson MJ, Sheehan D, Gaynor PJ, Marangell LB, Tanaka Y, Lipsius S, et al. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine. Int Clin Psychopharmacol. 2013;28(6):330–8 Epub 2013/07/23.

    Article  PubMed  Google Scholar 

  11. Jaracz J, Gattner K, Moczko J, Hauser J. Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression. General Hospital Psychiatry. 2014 Epub 2014/12/07.

    Google Scholar 

  12. Mitra R, Jones S. Adjuvant analgesics in cancer pain: a review. Am J Hospice Palliat Care. 2012;29(1):70–9 Epub 2011/06/30.

    Article  Google Scholar 

  13. Basbaum A, Fields H. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol. 1978;4:451–62.

    Article  CAS  PubMed  Google Scholar 

  14. De Felipe M, De Ceballos M, Gil CF. Chronic antidepressant treatment increases enkephalin levels in nucleus accumbens and striatum of the rat. Eur J Pharmacol. 1985;112:119.

    Article  PubMed  Google Scholar 

  15. Mico J, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006;27:348–54.

    Article  CAS  PubMed  Google Scholar 

  16. Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci: JPN. 2001;26(1):21–9 Epub 2001/02/24.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Liu J, Reid AR, Sawynok J. Spinal serotonin 5-HT7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors, are involved in antinociception by systemically administered amitriptyline. Eur J Pharmacol. 2013;698(1–3):213–9 Epub 2012/11/13.

    Article  CAS  PubMed  Google Scholar 

  18. Sawynok J, Reid AR, Fredholm BB. Caffeine reverses antinociception by amitriptyline in wild type mice but not in those lacking adenosine A1 receptors. Neurosci Lett. 2008;440(2):181–4 Epub 2008/06/20.

    Article  CAS  PubMed  Google Scholar 

  19. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev. 2003;55(1):1–20 Epub 2003/03/05.

    Article  CAS  PubMed  Google Scholar 

  20. Giardina E, Bigger J, Glassman A, Perel J, Kantor S. The electrocardiographic and antiarrhythmic effects of imipramine hydrocloride at therapeutic plasma concentrations. Circulation. 1979;60:1045–52.

    Article  CAS  PubMed  Google Scholar 

  21. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al. Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage J Can Pain Soc (Journal de la societe canadienne pour le traitement de la douleur). 2007;12(1):13–21 Epub 2007/03/21.

    Google Scholar 

  22. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76(20):1758–65 Epub 2011/04/13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Finnerup N, Otto M, McQuay H, Jensen T, Sindrup S. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain Manage Nurs Official J Am Soc Pain Manage Nurs. 2005;118:289–305.

    CAS  Google Scholar 

  24. Watson CP, Gilron I, Sawynok J, Lynch ME. Nontricyclic antidepressant analgesics and pain: are serotonin norepinephrine reuptake inhibitors (SNRIs) any better? Pain. 2011;152(10):2206–10 Epub 2011/07/05.

    Article  CAS  PubMed  Google Scholar 

  25. Vranken J. Mechanisms and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2009;9(1):71–8.

    Article  CAS  PubMed  Google Scholar 

  26. Liu WQ, Kanungo A, Toth C. Equivalency of tricyclic antidepressants in open-label neuropathic pain study. Acta Neurol Scand. 2014;129(2):132–41 Epub 2013/08/14.

    Article  CAS  PubMed  Google Scholar 

  27. Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindstrom T, Thorell LH. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain. 1997;13(4):313–23 Epub 1998/02/12.

    Article  CAS  PubMed  Google Scholar 

  28. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev (Online). 2012;12:CD008242 Epub 2012/12/14.

    Google Scholar 

  29. Hearn L, Moore RA, Derry S, Wiffen PJ, Phillips T. Desipramine for neuropathic pain in adults. Cochrane Database Syst Rev (Online). 2014;9:CD011003 Epub 2014/09/24.

    Google Scholar 

  30. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev (Online). 2012;7:CD008943 Epub 2012/07/13.

    Google Scholar 

  31. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009;374(9697):1252–61 Epub 2009/10/03.

    Article  CAS  PubMed  Google Scholar 

  32. Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA, J Am Med Assoc. 2013;310(24):2622–30 Epub 2013/12/26.

    Article  CAS  Google Scholar 

  33. Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA, J Am Med Assoc. 2001;285(17):2208–15 Epub 2001/05/18.

    Article  CAS  Google Scholar 

  34. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev (Online). 2014;1:CD007115 Epub 2014/01/05.

    Google Scholar 

  35. Giannantoni A, Porena M, Gubbiotti M, Maddonni S, Di Stasi SM. The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2014;83(2):400–5 Epub 2013/11/16.

    Article  PubMed  Google Scholar 

  36. Rowbotham M, Goli V, Kunz N, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double blind, placebo controlled study. Pain Manage Nurs Official J Am Soc Pain Manage Nurs. 2004;110:697–706.

    CAS  Google Scholar 

  37. Amr Y, Yousef A. Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic post-mastectomy pain. Clin J Pain. 2010;26:381–5.

    Article  PubMed  Google Scholar 

  38. Sindrup S, Bach F, Madsen C, Gram L, Jensen T. Venlafaxine versus imipramine in painful polyneuropathy: a randomized controlled trial. Neurology. 2003;60:1284–9.

    Article  CAS  PubMed  Google Scholar 

  39. Ozyalcin S, Talu G, Kizitlan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the propylaxis of migraine. Headache. 2005;45:144–52.

    Article  PubMed  Google Scholar 

  40. Zissis N, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis GS, et al. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia Int J Headache. 2007;27:315–24.

    Article  CAS  Google Scholar 

  41. Funai Y, Funao T, Ikenaga K, Takahashi R, Hase I, Nishikawa K. Use of tricyclic antidepressants as analgesic adjuvants results in nonhazardous prolongation of the QTc interval. Osaka City Med J. 2014;60(1):11–9 Epub 2014/10/03.

    CAS  PubMed  Google Scholar 

  42. Martin T. Serotonin syndrome. Ann Emerg Med. 1996;28(5):520–6.

    Article  CAS  PubMed  Google Scholar 

  43. Zajecka J, Fawcett J, Amsterdam J, Quitkin F, Reimherr F, Rosenbaum J, et al. Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. J Clin Psychopharmacol. 1998;18(3):193–7.

    Article  CAS  PubMed  Google Scholar 

  44. Burchiel K. Carbamezepine inhibits spontaneous activity in experimental neuromaas. Exp Neurol. 1988;102(2):249–53.

    Article  CAS  PubMed  Google Scholar 

  45. Devour M. Pathophysiology of injured nerve. In: Wall P, Melzack E, editors. Textbook of pain. 3rd ed. London, England: Churchill Livingstone; 1994. p. 79–100.

    Google Scholar 

  46. England JD, Happel LT, Kline DG, Gamboni F, Thouron CL, Liu ZP, et al. Sodium channel accumulation in humans with painful neuromas. Neurology. 1996;47(1):272–6 Epub 1996/07/01.

    Article  CAS  PubMed  Google Scholar 

  47. Wall P, Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain Manage Nurs Official J Am Soc Pain Manag Nurs. 1983;17(4):321–39.

    CAS  Google Scholar 

  48. Yang JL, Xu B, Li SS, Zhang WS, Xu H, Deng XM, et al. Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats. Mol Brain. 2012;5:18 Epub 2012/06/01.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharmacal Res. 2013;36(3):237–51 Epub 2013/02/26.

    Article  CAS  Google Scholar 

  50. Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manage J Can Pain Soc (journal de la societe canadienne pour le traitement de la douleur). 2014;19(6):328–35 Epub 2014/12/06.

    Google Scholar 

  51. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237–51 Epub 2007/10/09.

    Article  CAS  PubMed  Google Scholar 

  52. O’Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009;122(10 Suppl):S22–32 Epub 2009/10/07.

    Article  PubMed  Google Scholar 

  53. Miljevic C, Crnobaric C, Nikolic S, Lecic-Tosevski D. A case of pregabalin intoxication. Psychiatrike = Psychiatriki. 2012;23(2):162–5 Epub 2012/07/17.

    Google Scholar 

  54. Shamsi Meymandi M, Keyhanfar F. Assessment of the antinociceptive effects of pregabalin alone or in combination with morphine during acetic acid-induced writhing in mice. Pharmacol Biochem Behav. 2013;110:249–54 Epub 2013/08/08.

    Google Scholar 

  55. Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice AS, et al. Antiepileptic drugs for neuropathic pain and fibromyalgia—an overview of Cochrane reviews. Cochrane Database Syst Rev (Online). 2013;11:CD010567 Epub 2013/11/13.

    Google Scholar 

  56. Iwamoto T, Takasugi Y, Higashino H, Ito H, Koga Y, Nakao S. Antinociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation. J Anesthesia. 2011;25(1):78–86 Epub 2010/11/30.

    Article  Google Scholar 

  57. Tomic MA, Micov AM, Stepanovic-Petrovic RM. Levetiracetam interacts synergistically with nonsteroidal analgesics and caffeine to produce antihyperalgesia in rats. J Pain Official J Am Pain Soc. 2013;14(11):1371–82 Epub 2013/08/21.

    Article  CAS  Google Scholar 

  58. Miller S. The acute and preventative treatment of episodic migraine. Ann Indian Academy Neurol. 2012;15(Suppl 1):S33–9 Epub 2012/10/02.

    Article  Google Scholar 

  59. Smith HS, Argoff CE. Pharmacological treatment of diabetic neuropathic pain. Drugs. 2011;71(5):557–89 Epub 2011/03/30.

    Article  CAS  PubMed  Google Scholar 

  60. Raptis E, Vadalouca A, Stavropoulou E, Argyra E, Melemeni A, Siafaka I. Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study. Pain Pract Official J World Inst Pain. 2014;14(1):32–42. Epub 2013/03/08.

    Google Scholar 

  61. Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain—a systematic review of randomized controlled trials. Pain. 2006;126(1–3):91–101 Epub 2006/07/19.

    Article  CAS  PubMed  Google Scholar 

  62. Wibbenmeyer L, Eid A, Liao J, Heard J, Horsfield A, Kral L, et al. Gabapentin is ineffective as an analgesic adjunct in the immediate postburn period. J Burn Care Res Official Publ Am Burn Assoc. 2014;35(2):136–42 Epub 2013/03/21.

    Article  Google Scholar 

  63. Paul JE, Nantha-Aree M, Buckley N, Cheng J, Thabane L, Tidy A, et al. Gabapentin does not improve multimodal analgesia outcomes for total knee arthroplasty: a randomized controlled trial. Can J Anaesth (Journal canadien d’anesthesie). 2013;60(5):423–31 Epub 2013/03/13.

    Article  Google Scholar 

  64. Sawan H, Chen AF, Viscusi ER, Parvizi J, Hozack WJ. Pregabalin reduces opioid consumption and improves outcome in chronic pain patients undergoing total knee arthroplasty. Physician Sportsmedicine. 2014;42(2):10–8 Epub 2014/05/31.

    Article  PubMed  Google Scholar 

  65. Panah Khahi M, Marashi S, Khajavi MR, Najafi A, Yaghooti A, Imani F. Postoperative gabapentin to prevent postoperative pain: a randomized clinical trial. Anesthesiol Pain Med. 2012;2(2):77–80. Epub 2013/11/14.

    Google Scholar 

  66. Ture H, Sayin M, Karlikaya G, Bingol CA, Aykac B, Ture U. The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study. Anesth Analg. 2009;109(5):1625–31 Epub 2009/08/29.

    Article  PubMed  CAS  Google Scholar 

  67. Khosravi MB, Azemati S, Sahmeddini MA. Gabapentin versus naproxen in the management of failed back surgery syndrome; a randomized controlled trial. Acta Anaesthesiol Belg. 2014;65(1):31–7 Epub 2014/07/06.

    CAS  PubMed  Google Scholar 

  68. Olesen SS, Bouwense SA, Wilder-Smith OH, van Goor H, Drewes AM. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology. 2011;141(2):536–43 Epub 2011/06/21.

    Article  CAS  PubMed  Google Scholar 

  69. Kustermann A, Mobius C, Oberstein T, Muller HH, Kornhuber J. Depression and attempted suicide under pregabalin therapy. Ann Gen Psychiatry. 2014;13(1):37 Epub 2014/12/10.

    Google Scholar 

  70. Fukasawa H, Muratake H, Nagae M, Sugiyama K, Shudo K. Transdermal administration of aqueous pregabalin solution as a potential treatment option for patients with neuropathic pain to avoid central nervous system-mediated side effects. Bio Pharm Bull. 2014;37(11):1816–9 Epub 2014/09/13.

    Article  CAS  Google Scholar 

  71. Office of diversion control. schedules of controlled substances: placement of Pregabalin into Schedule V. Washington, D.C.: U.S. Department of Justice 2005 [cited 2015 27 February]; Available from: http://www.deadiversion.usdoj.gov/fed_regs/rules/2005/fr0728.htm.

  72. Andersohn F, Schade R, Willich SN, Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 2010;75(4):335–40 Epub 2010/07/28.

    Article  CAS  PubMed  Google Scholar 

  73. Kalinin VV. Suicidality and antiepileptic drugs: is there a link? Drug Safety Int J Med Toxicol Drug Experience. 2007;30(2):123–42 Epub 2007/01/27.

    Article  CAS  Google Scholar 

  74. Panday K, Gona A, Humphrey MB. Medication-induced osteoporosis: screening and treatment strategies. Ther Adv Musculoskeletal Dis. 2014;6(5):185–202 Epub 2014/10/25.

    Article  CAS  Google Scholar 

  75. Wu FJ, Sheu SY, Lin HC. Osteoporosis is associated with antiepileptic drugs: a population-based study. Epileptic Dis Int Epilepsy J Videotape. 2014;16(3):333–42 Epub 2014/08/29.

    Google Scholar 

  76. Witenko C, Moorman-Li R, Motycka C, Duane K, Hincapie-Castillo J, Leonard P, et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P & T: Peer-Reviewed J Formulary Manage. 2014;39(6):427–35 Epub 2014/07/23.

    Google Scholar 

  77. Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–91.

    Article  PubMed  Google Scholar 

  78. DailyMed.com. Carisoprodol. Bethesda, MD: US National Library of Medicine; 2012 [updated January 2012; cited 2014 29 December]; Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1fa79b11-6491-4543-8548-8aaa624f7ff8#section-1.

  79. The American Geriatrics Society 2012 Beers Criteria Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in the elderly. J Am Geriatric Soc. 2012;60(4):616–31.

    Google Scholar 

  80. Reeves RR, Beddingfield JJ, Mack JE. Carisoprodol withdrawal syndrome. Pharmacotherapy. 2004;24(12):1804–6 Epub 2004/12/09.

    Article  PubMed  Google Scholar 

  81. Gatch MB, Nguyen JD, Carbonaro T, Forster MJ. Carisoprodol tolerance and precipitated withdrawal. Drug Alcohol Depend. 2012;123(1–3):29–34 Epub 2011/11/08.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. DailyMed.com. AMRIX-cyclobenzaprine hydrochloride capsule, extended release. Bethesda, MD: U.S. National Library of Medicine; 2011 [updated February 2011; cited 2014 29 December]; Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8ca1d80-6ea9-4a3f-ab06-beedf845de8f.

  83. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum. 1994;37(1):32–40 Epub 1994/01/01.

    Article  CAS  PubMed  Google Scholar 

  84. Douglass MA, Levine DP. Hallucinations in an elderly patient taking recommended doses of cyclobenzaprine. Arch Intern Med. 2000;160(9):1373.

    Article  CAS  PubMed  Google Scholar 

  85. DailyMed.com. Skelaxin-metaxalone tablet. Bethesda, MD: U.S. National Library of Medicine; 2014 [updated April 2014; cited 2014 29 December]; Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a4163f2-c553-4d14-7e98-d14c5c7f772a.

  86. Harden RN, Argoff C. A review of three commonly prescribed skeletal muscle relaxants. J Back Musculoskelet Rehabil. 2000;15(2):63–6 Epub 2000/01/01.

    CAS  PubMed  Google Scholar 

  87. See S, Ginzburg R. Skeletal muscle relaxants. Pharmacotherapy. 2008;28(2):207–13.

    Article  CAS  PubMed  Google Scholar 

  88. See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician. 2008;78(3):365–70.

    PubMed  Google Scholar 

  89. Chou R. Pharmacological management of low back pain. Drugs. 2010;70(4):387–402.

    Article  CAS  PubMed  Google Scholar 

  90. Richards BL, Whittle SL, Buchbinder R. Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev (Online). 2012;1:CD008922 Epub 2012/01/20.

    Google Scholar 

  91. Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl. 2012;90:34–9 Epub 2012/09/04.

    Article  CAS  PubMed  Google Scholar 

  92. Luo X, Pietrobon R, Curtis LH, Hey LA. Prescription of non-steroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States. Spine. 2004;29(23):E531–7.

    Article  PubMed  Google Scholar 

  93. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev (Online). 2003;(2):CD004252 Epub 2003/06/14.

    Google Scholar 

  94. Bernstein E, Carey TS, Garrett JM. The use of muscle relaxant medications in acute low back pain. Spine. 2004;29(12):1346–51 Epub 2004/06/10.

    Article  PubMed  Google Scholar 

  95. Dillon C, Paulose-Ram R, Hirsch R, Gu Q. Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III). Spine. 2004;29(8):892–6 Epub 2004/04/15.

    Article  PubMed  Google Scholar 

  96. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Cochrane Back Review G. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the Cochrane collaboration. Spine. 2003;28(17):1978–92 Epub 2003/09/16.

    Google Scholar 

  97. Boyles W, Glassman J, Soyka J. Management of acute musculoskeletal conditions: thoracolumbar strain or sprain. A double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Today’s Ther Trends. 1983;1(1–16).

    Google Scholar 

  98. Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther. 2004;26(9):1355–67 Epub 2004/11/09.

    Article  CAS  PubMed  Google Scholar 

  99. Rossi M, Ianigro G, Liberatoscioli G, Di Castelnuovo A, Grimani V, Garofano A, et al. Eperisone versus tizanidine for treatment of chronic low back pain. Minerva Med. 2012;103(3):143–9 Epub 2012/06/02.

    CAS  PubMed  Google Scholar 

  100. Chandanwale AS, Chopra A, Goregaonkar A, Medhi B, Shah V, Gaikwad S, et al. Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial. J Postgrad Med. 2011;57(4):278–85 Epub 2011/11/29.

    Article  CAS  PubMed  Google Scholar 

  101. Ralph L, Look M, Wheeler W, Sacks H. Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm. Curr Med Res Opin. 2008;24(2):551–8 Epub 2008/01/16.

    Article  CAS  PubMed  Google Scholar 

  102. Malanga GA, Ruoff GE, Weil AJ, Altman CA, Xie F, Borenstein DG. Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical design. Curr Med Res Opin. 2009;25(5):1179–96 Epub 2009/03/28.

    Article  CAS  PubMed  Google Scholar 

  103. Weil AJ, Ruoff GE, Nalamachu S, Altman CA, Xie F, Taylor DR. Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis. Postgrad Med. 2010;122(4):158–69 Epub 2010/08/03.

    Article  PubMed  Google Scholar 

  104. Bramness JG, Skurtveit S, Morland J, Engeland A. The risk of traffic accidents after prescriptions of carisoprodol. Accident Anal Prev. 2007;39(5):1050–5 Epub 2007/09/15.

    Article  Google Scholar 

  105. Peron EP, Marcum ZA, Boyce R, Hanlon JT, Handler SM. Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother. 2011;9(1):1–10 Epub 2011/04/05.

    Article  PubMed  PubMed Central  Google Scholar 

  106. SAMHSA. Drug abuse warning network, 2011: national estimates of drug-related emergency department visits. Rockville, MD: Health and Human Services; 2013.

    Google Scholar 

  107. Reeves RR, Burke RS. Carisoprodol: abuse potential and withdrawal syndrome. Current Drug Abuse Rev. 2010;3(1):33–8.

    Article  CAS  Google Scholar 

  108. Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM. Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis. 1999;18(2):51–6 Epub 1999/05/20.

    Article  CAS  PubMed  Google Scholar 

  109. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–20 Epub 2005/03/24.

    Article  CAS  PubMed  Google Scholar 

  110. Jimenez Andrade JM, Mantyh P. Cancer pain: from the development of mouse models to human clinical trials translational pain research: from mouse to man. Kruger L, Light AR, editors. Boca Raton, FL: Llc.; 2010.

    Google Scholar 

  111. Ables AZ, Nagubilli R. Prevention, recognition, and management of serotonin syndrome. Am Fam Physician. 2010;81(9):1139–42 Epub 2010/05/04.

    PubMed  Google Scholar 

  112. Prakash S, Belani P, Trivedi A. Headache as a presenting feature in patients with serotonin syndrome: a case series. Cephalalgia Int J Headache. 2013 Epub 2013/07/06.

    Google Scholar 

  113. Breivik H. Pain management discussion forum: serious interaction among frequently used drugs for chronic pain. J Pain Palliat Care Pharmacother. 2014;28(2):170–1 Epub 2014/05/08.

    Article  PubMed  Google Scholar 

  114. Park SH, Wackernah RC, Stimmel GL. Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants? J Pharm Pract. 2014;27(1):71–8 Epub 2013/10/25.

    Article  PubMed  Google Scholar 

  115. Giummarra MJ, Gibson SJ, Allen AR, Pichler AS, Arnold CA. Polypharmacy and chronic pain: harm exposure is not all about the opioids. Pain Med (Malden, Mass). 2014 Epub 2014/10/04.

    Google Scholar 

  116. Pergolizzi JV. Quantifying the impact of drug-drug interactions associated with opioids. Am J Managed Care. 2011;17(Suppl 11):S288–92 Epub 2011/10/26.

    Google Scholar 

  117. Pergolizzi JV, Jr., Labhsetwar SA, Amy Puenpatom R, Ben-Joseph R, Ohsfeldt R, Summers KH. Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioids. Pain Pract Official J World Inst Pain. 2012;12(1):45–56 Epub 2011/09/20.

    Google Scholar 

  118. Pergolizzi JV Jr, Labhsetwar SA, Puenpatom RA, Joo S, Ben-Joseph R, Summers KH. Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions. Pain Pract Official J World Inst Pain. 2011;11(4):325–36 Epub 2011/01/05.

    Article  Google Scholar 

  119. Pergolizzi JV Jr, Labhsetwar SA, Puenpatom RA, Joo S, Ben-Joseph RH, Summers KH. Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids. Pain Pract Official J World Inst Pain. 2011;11(3):230–9 Epub 2010/09/03.

    Article  Google Scholar 

  120. Razazian N, Baziyar M, Moradian N, Afshari D, Bostani A, Mahmoodi M. Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial. Neurosciences (Riyadh, Saudi Arabia). 2014;19(3):192–8 Epub 2014/07/02.

    Google Scholar 

  121. Banerjee M, Pal S, Bhattacharya B, Ghosh B, Mondal S, Basu J. A comparative study of efficacy and safety of gabapentin versus amitriptyline as coanalgesics in patients receiving opioid analgesics for neuropathic pain in malignancy. Indian J Pharmacol. 2013;45(4):334–8 Epub 2013/09/10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Keskinbora K, Pekel AF, Aydinli I. [Comparison of efficacy of gabapentin and amitriptyline in the management of peripheral neuropathic pain]. Agri: Agri (Algoloji) Dernegi’nin Yayin organidir = The journal of the Turkish Society of Algology. 2006;18(2):34–40 Epub 2006/11/08. Periferik noropatik agrinin kontrolunde gabapentin ve amitriptilinin etkinliginin karsilastirilmasi.

    Google Scholar 

  123. Arai YC, Matsubara T, Shimo K, Suetomi K, Nishihara M, Ushida T, et al. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. J Anesth. 2010;24(3):407–10 Epub 2010/03/11.

    Article  PubMed  Google Scholar 

  124. Nishihara M, Arai YC, Yamamoto Y, Nishida K, Arakawa M, Ushida T, et al. Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Physician. 2013;16(5):E547–52 Epub 2013/10/01.

    PubMed  Google Scholar 

  125. Garassino MC, Piva S, La Verde N, Spagnoletti I, Iorno V, Carbone C, et al. Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients. PloS One. 2013;8(4):e59981 Epub 2013/04/12.

    Google Scholar 

  126. Srinath A, Young E, Szigethy E. Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside. Inflamm Bowel Dis. 2014;20(12):2433–49 Epub 2014/09/11.

    Article  PubMed  Google Scholar 

  127. Jongen JL, Huijsman ML, Jessurun J, Ogenio K, Schipper D, Verkouteren DR, et al. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects. J Pain Symptom Manage. 2013;46(4):581–90 e1 Epub 2013/02/19.

    Google Scholar 

  128. Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain. 1999;80(1–2):45–55 Epub 1999/04/16.

    Article  CAS  PubMed  Google Scholar 

  129. Mumoli N, Cocciolo M, Vitale J, Mantellassi M, Sabatini S, Gambaccini L, et al. Diabetes mellitus associated with clomipramine treatment: a retrospective analysis. Acta Diabetol. 2014;51(1):167–8 Epub 2013/07/05.

    Article  CAS  PubMed  Google Scholar 

  130. Sawynok J, Esser MJ, Reid AR. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain. 1999;82(2):149–58 Epub 1999/09/01.

    Article  CAS  PubMed  Google Scholar 

  131. Chappel A, Ossanna M, Liu-Seifert H, Ivengar S, Skjarevski V, Li L, et al. Duloxetine, a centrally-acting analgesic in the treatment of patients with osteoarthritis knee pain: a 13 week, randomized, placebo-controlled trial. Pain. 2009;146:253–60.

    Article  CAS  Google Scholar 

  132. Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract Official J World Inst Pain. 2013;13(3):239–52 Epub 2012/06/22.

    Article  Google Scholar 

  133. Paoli F. G C, p C. [Prelimary notes on the effect of imipramine in depressed states]. Rev Neurol. 1960;2:503.

    Google Scholar 

  134. Mease P. D C. The efficacy and safety of milnacipran for the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36(2):398–409.

    Article  CAS  PubMed  Google Scholar 

  135. Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev (Online). 2011(12):CD006528 Epub 2011/12/14.

    Google Scholar 

  136. Hall H, Ogren S-O. Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol. 1981;70:393–407.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Johns Hopkins University School of Medicine, 3384 Woods Edge Circle, Suite 102, Bonita Springs, FL, 34134, USA

    Joseph V. Pergolizzi

Authors
  1. Joseph V. Pergolizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph V. Pergolizzi .

Editor information

Editors and Affiliations

  1. Shrewsbury, New Jersey, USA

    Peter S. Staats

  2. Comprehensive Pain Medicine, Pompano Beach, Florida, USA

    Sanford M. Silverman

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pergolizzi, J.V. (2016). Adjuvant Agents in Chronic Pain Therapy. In: Staats, P., Silverman, S. (eds) Controlled Substance Management in Chronic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-30964-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30964-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30962-0

  • Online ISBN: 978-3-319-30964-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation